The advantage of dual agonism is apparent in the Citrobacter-colitis model, which most robustly recapitulates the paradoxical immune suppression in the setting of dysbiosis that is seen in IBD, and most prominently in CD51,61,62. The gene discussed is ITGAV; the disease is inflammatory bowel disease.